University of Cambridge Featured PhD Programmes
University of Sussex Featured PhD Programmes
University of Oxford Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
The University of Manchester Featured PhD Programmes
"behaviour"×
10 miles

Pharmacology / Toxicology (behaviour) PhD Projects, Programs & Scholarships

We have 19 Pharmacology / Toxicology (behaviour) PhD Projects, Programs & Scholarships

  • "behaviour" ×
  • Pharmacology / Toxicology×
  • clear all
Order by 
Showing 1 to 15 of 19
  Intergrating feedback from Electronic Healthcare Data in medication adherence support in primary care in Scotland for pattients with polypharmacy
  Dr R Paterson, Dr A Mair
Application Deadline: 17 December 2019

Funding Type

PhD Type

Adherence to medications is increasingly important for population health, as chronic conditions become more prevalent. Electronic Healthcare Data (EHD) can be used to calculate adherence and visualise medication histories.
  EASTBIO: Towards a systems-level understanding of visually-guided reaching
  Dr I Duguid, Dr M H Henning
Application Deadline: 5 January 2020

Funding Type

PhD Type

Deanery of Biomedical Sciences. Reaching and grasping is an essential component of our everyday lives. We use visual information regarding object type and position and combine this with exquisite and adaptable motor control to successfully interact with objects in our environment.
  MRC DTP 4 Year PhD Programme: Early life adversity and hippocampal dysfunction in rodents: the impact of novel, fast-acting antidepressants
  Dr S Martin, Prof J Lambert
Application Deadline: 11 January 2020

Funding Type

PhD Type

This project is offered as part of the University of Dundee 4-year MRC DTP Programme “Quantitative and Interdisciplinary approaches to biomedical science”.
  Identification of novel glucose-dependent alterations responsible for vascular dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr R Sturmey
Application Deadline: 31 March 2020

Funding Type

PhD Type

Diabetes is a growing global healthcare problem. The majority of people living with diabetes have Type 2 diabetes mellitus (T2DM), characterised by a resistance of the body to the action of insulin.
  Developing streamlined approaches to assessing the systemic and hepatic effects of nanomaterials (EPS2020/08)
  Prof V Stone
Application Deadline: 28 February 2020

Funding Type

PhD Type

Integrated approaches to testing and assessment (IATAs) are under development to assess the hazards of nanomaterials via ingestion, inhalation and dermal application.
  RNA Methylation in normal and malignant blood development
  Dr L. Kats
Applications accepted all year round

Funding Type

PhD Type

As is the case with DNA and histones, RNA can also be modified and indeed more than 100 chemical groups that decorate all four canonical RNA nucleotides have been described.
  Accurate energy evaluation of receptor-ligand interaction
  Prof P Popelier, Dr S De Visser
Applications accepted all year round

Funding Type

PhD Type

Drug design routinely uses existing computational methods to evaluate the interaction energy between receptor (protein) and ligand (drug) in molecular docking.
  Epigenetic mechanisms of behavioural, placental and cognitive impairment in a neurodevelopmental model for schizophrenia
  Dr R Hager, Prof J Neill, Dr J Glazier
Applications accepted all year round

Funding Type

PhD Type

A fundamental question in disease research is how stressors experienced during critical developmental periods influence the genesis or ‘programming’ of adult disease (Estes & McAllister 2016).
  An Organ on a Chip Platform for Biomedical Applications
  Dr P De Bank
Applications accepted all year round

Funding Type

PhD Type

Organ on a chip devices are an emerging technology which employ microfluidics to grow 3D tissues, mimicking the physiological conditions found in vivo.
  Associative memory: the role of alpha7 nicotinic receptors in the ventral hippocampus
  Dr C P Bailey, Prof S Wonnacott
Application Deadline: 1 January 2020

Funding Type

PhD Type

The University of Bath is inviting applications for the following PhD project in collaboration with RenaSci Limited. Supervisory Team.
  Single molecule imaging of RAMP-GPCR complexes; towards a new paradigm in pharmacology?
  Prof D Calebiro
Application Deadline: 12 January 2020

Funding Type

PhD Type

We are seeking a highly motivated PhD candidate to join our interdisciplinary team at the Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham (UK), to work on a collaborative project with the groups of Professor David Poyner (Aston University) and Dr Graham Ladds (University of Cambridge).
  Development of stimuli-responsive metallosupramolecular architectures for sensing and/or delivery of medicine for the treatment of solid tumours
  Research Group: Chemistry and Biosciences
  Dr M Najafzadeh, Dr S Pike
Applications accepted all year round

Funding Type

PhD Type

Colorectal cancer is among the most commonly diagnosed cancer and ranks as the third leading cause of cancer related mortality worldwide.
  Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer’s disease.
  Dr M Collins
Application Deadline: 6 January 2020

Funding Type

PhD Type

Project description. Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterised by the deposition and accumulation of amyloid beta plaques and phosphorylated tau filaments in the brain, the latter correlating with the onset of symptoms.
  Live imaging of neural circuits mediating pain
  Dr A Nikolaev, Dr E Seward
Applications accepted all year round

Funding Type

PhD Type

The aim of this project is to characterize the neuronal circuitry involved in pain signaling in genetically modified zebrafish expressing fluorescent reporters of activity.
  Novel therapeutic approaches for the treatment of Duchenne muscular dystrophy.
  Prof S Winder
Applications accepted all year round

Funding Type

PhD Type

Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene leading to loss of the cytoskeletal protein dystrophin.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.